2019-07 |
ATP-binding cassette transporter, ABCG2, activation is responsible for chemo-resistant, SIK3 low expressed ovarian cancer |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 5146. |
|
2019-07 |
Cathepsin S inhibition alleviates oxaliplatin-induced peripheral neuropathy through regulation of Ca2+homeostasis |
Cancer Research. 2019 Jul;79(13, Suppl.):Abstract number 2942. |
|
2019-06-24 |
Alteration of epigenetic modifiers in pancreatic cancer and its clinical implication |
Journal of Clinical Medicine. 2019 Jun 24;8(6):Article number 903. |
|
2019-06-21 |
Identification of phenothiazine as an ETV1targeting agent in gastrointestinal stromal tumors using the Connectivity Map |
International Journal of Oncology. 2019 Jun 21;55(2):536-546. |
|
2019-06-14 |
Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion |
Nature Communications. 2019 Jun 14;10:Article number 2625. |
|
2019-06-10 |
Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma |
BMC Cancer. 2019 Jun 10;19:Article number 560. |
|
2019-06-06 |
Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells |
Oncogene. 2019 Jun 9;38(23):4480-4495. |
|
2019-06-01 |
Laminin gamma2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via intergrin alpha3-dependent uptake by lymphatic endothelial cells |
International Journal of Cancer. 2019 Jun 1;144(11):2795-2810. |
|
2019-06 |
Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial |
Head and Neck. 2019 Jun;41(6):1703-1712. |
|
2019-06 |
Validation of alcohol flushing questionnaire to identify ALDH2 status in a case-control study of head and neck cancer |
Alcoholism, Clinical and Experimental Research. 2019 Jun;43(6):1225-1233. |
|
2019-06 |
MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1 |
Journal of Experimental and Clinical Cancer Research. 2019 Jun;38:Article number 281. |
|
2019-06 |
Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment: A study protocol |
BMC Cancer. 2019 Jun;19:Article number 640. |
|
2019-06 |
Comparison of oncologic outcomes in laparoscopic versus open surgery for non-metastatic colorectal cancer: Personal experience in a single institution |
Journal of Clinical Medicine. 2019 Jun;8(6):Article number 875. |
|
2019-05-28 |
ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma |
Cell Death and Disease. 2019 May 28;10(6):Article number 408. |
|
2019-05-27 |
Deciphering the potential role of hox genes in pancreatic cancer |
Cancers. 2019 May 27;11(5):Article number 734. |
|
2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer |
Molecular Cancer. 2019 May 20;18:Article number 96. |
|
2019-05-17 |
Next viable routes to targeting pancreatic cancer stemness: Learning from clinical setbacks |
Journal of Clinical Medicine. 2019 May 17;8(5):Article number 702. |
|
2019-05 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan |
Journal of Thoracic Oncology. 2019 May;14(5):784-792. |
|
2019-05 |
Association of daily aspirin therapy with risk of hepatocellular carcinoma in patients with chronic hepatitis B |
JAMA Internal Medicine. 2019 May 18;179(5):633-640. |
|
2019-05 |
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial |
Journal of Geriatric Oncology. 2019 May;10(3):427-435. |
|
2019-05 |
TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response |
PLoS Genetics. 2019 May;15(5):Article number e1007947. |
|
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14) |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 4101. |
|
2019-05 |
Oral paclitaxel in the treatment of metastatic breast cancer (MBC) patients |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number 1084. |
|
2019-05 |
A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e17534. |
|
2019-05 |
Recapitulation of inflammatory and immune-evasive subtypes of oral cancer cells in immunodeficient mice |
Journal of Clinical Oncology. 2019 May;37(15, Suppl. S):Abstract number e14199. |
|